Asia Pacific Glucose Monitoring Devices Market Industry Analysis and Market Forecast 2017 - 2022

  • ID: 4387678
  • Report
  • Region: Asia, Asia Pacific
  • 113 pages
  • Mordor Intelligence
1 of 3
The Asia-Pacific glucose monitoring devices market is projected to reach USD 3.55 billion by 2019, growing at a CAGR of 7.88% during the forecast period from 2014 to 2019.

Asia-Pacific Glucose Monitoring Devices Market-Market Dynamics

Asia-Pacific is at the forefront of the diabetic epidemic with more than 110 million people suffering from diabetes in 2013 and this number is expected to increase in the coming years. 3.8% of the total APAC population was suffering from diabetes in 2015. With the increasing rate of diabetes cases, self-monitoring with glucose meters and strips has become an important aspect of diabetes care and management.

Drivers

Some of the factors driving the growth of the market are:

Increasing technological innovations in diagnosis and monitoring of diabetes

Growing incidence of people suffering from diabetes

Early detection of hypo- and hyperglycemic diabetes

Increased demand for continuous glucose monitoring devices

Restraints

The market is constrained by the following factors:

High cost associated with diagnosis and treatment

Reimbursement issues

Patent expiry

The Asia-Pacific glucose monitoring devices market is segmented into blood glucose meters, blood glucose testing strips, lancets, and continuous glucose monitoring devices. By geography, the market is segmented into India, China, and Japan. India and China are the growing markets because of their increasing population.

Self-Monitoring Blood Glucose (SMBG) markets across Asia Pacific are still in the growing phase. Mature markets include Singapore, Hong Kong, South Korea, and Taiwan, which have well-defined hospital market segments and operate through large-scale tenders for the purchase of strips. In China, the market size for self-monitoring blood glucose is projected to reach USD 25.2 million by 2019. The market is driven by the increasing diabetic population and continuous innovations in the diagnosis and treatment of diabetes. The South Korean market is the most competitive, with a significant number of market players and strong local competition.

Roche Diabetes Care (RDC) retains the marketleading position across Asia-Pacific with a market share of 46.2%, followed by Life Scan, which occupies the second spot in the market.

Key Deliverables:

Market analysis for the Asia-Pacific glucose monitoring devices market, with region-specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the Asia-Pacific glucose monitoring devices market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. INTRODUCTION
1.1 Report Description
1.2 Research Methodology
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
3.1 Market Size Estimation
3.2 Market Trends and Forecasts
3.3 MARKET DRIVERS
3.3.1 Technological Innovations
3.3.2 Convenience of CGM over conventional monitoring
3.3.3 Early Detection of Hypo and Hyperglycemic
3.3.4 Global rise in diabetic population
3.4 MARKET RESTRAINTS
3.4.1 Less Attractive Reimbursement Coverage
3.4.2 Reimbursement Issues
3.4.3 Patent expiry depleted profit of market
3.5 PorterFive Force Analysis of the Asia-Pacific Glucose Monitoring Device Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive rivalry
4. ASIA-PACIFIC GLUCOSE MONITORING DEVICE MARKET- SEGMENTATION
4.1 GLUCOSE MONITORING DEVICES
4.1.1 Blood Glucose Meter
4.1.2 Blood Glucose Testing Strips
4.1.3 Lancets
4.1.4 Continuous Glucose Monitoring Devices (CGM)
4.1.5 Others
4.2 BY GEOGRAPHY
4.2.1 India
4.2.2 China
4.2.3 Japan
5. COMPETITIVE ANALYSIS
5.1 Introduction
5.2 Mergers & Acquisitions
5.3 Expansions
5.4 New Product Launches
5.5 Collaborations
5.6 Market Share Analysis
6. COMPANY PROFILES
6.1 Abbott Laboratories
6.2 LifeScan
6.3 Arkray, Inc.
6.4 Roche
6.5 Apex Biotechnology Corp.
6.6 Ypsomed AG
7. APPENDIX
7.1 Abbreviations
7.2 Sources
7.3 Bibliography
7.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll